Conclusion
The emergence of non-invasive neurotech represents a significant shift in the landscape of medical technology. By offering the potential for targeted brain stimulation without the risks associated with invasive procedures, these technologies could revolutionize the treatment of a wide range of mental health and metabolic conditions.
Companies like Neurovalens are at the forefront of this revolution, developing a portfolio of treatments that could offer new hope to millions of patients worldwide. Their approach, focusing on specific conditions and seeking robust regulatory approval, sets a high bar for the industry and could help establish non-invasive neurotech as a credible and effective treatment modality.